Analyst firms · Morgan Stanley · CI

Morgan Stanley CI price target and rating history

The Cigna Group (CI) · Health Care

Morgan Stanley rates The Cigna Group (CI) Overweight with a $347 price target, as of its latest action on Nov 23, 2022. It has published 7 rating actions on CI since August 2021, including 1 upgrade and 2 downgrades. Across 6 firms with a CI price target in the last 12 months, the median target is $305.50.

Current rating
Overweight
Price target
$347
Median target, all firms
$305.50
Actions on CI
7

Morgan Stanley price target on CI

$347$291$23520222023202420252026
Morgan Stanley price target on CI, each point a stated target, August 2021 to November 2022.

Every Morgan Stanley rating on CI

How other firms rate CI

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Evercore ISIIn-line$290Sep 9, 2026
JefferiesHold$307Aug 4, 2026
Raymond JamesOutperform$320Aug 3, 2026
BarclaysEqual Weight$304May 26, 2026
Deutsche BankHold$302May 20, 2026
BernsteinOutperform$358Mar 12, 2026

Questions about Morgan Stanley and CI

What is Morgan Stanley's price target for CI?
Morgan Stanley's latest stated price target for The Cigna Group (CI) is $347, from its action on Nov 23, 2022.
What is Morgan Stanley's rating on CI?
Morgan Stanley rates CI Overweight, a bullish rating, as of Nov 23, 2022.
When did Morgan Stanley last change its view on CI?
On Nov 23, 2022, Morgan Stanley resumes coverage at Overweight, price target $318 to $347.
How does Morgan Stanley's CI target compare with other analysts?
Across 6 firms with a CI price target in the last 12 months, the median target is $305.50.

More CI rating histories

All Morgan Stanley ratingsCI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.